WHO ICTRP trial
Multicenter, randomized, double-blind, and parallel active controlled trial for…
ChiCTR2000040602 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2000040602 |
|---|---|
| Public title | Multicenter, randomized, double-blind, and parallel active controlled trial for comparing the efficacy and safety of Haizheng recombinant human - mouse chimeric anti-CD20 monoclonal antibody injection (HS006) combined with CHOP(Hi-chop) and Rituximab combined with CHOP(R-chop) in initial treatment for patients with diffuse large B |
| Scientific title | Multicenter, randomized, double-blind, and parallel active controlled trial for comparing the efficacy and safety of Haizheng recombinant human - mouse chimeric anti-CD20 monoclonal antibody injection (HS006) combined with CHOP(Hi-chop) and Rituximab combined with CHOP(R-chop) in initial treatment… |
| Primary sponsor | Center for Cancer Prevention and Treatment of Sun Yat-Sen University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 3 |
| Countries | China |
| Conditions | Diffuse large B cell lymphoma |
| Interventions | Experimental group:Hi-chop;control group:R-chop |
| Registration date | Dec 3, 2020 |
| Target size | Experimental group:320;control group:160 |
| Secondary IDs | CTR20180855 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: